In the stock market, certain gems often lurk in the shadows, awaiting discovery by savvy investors. As the market enters 2024, three under-the-radar stocks to buy are poised to break free from obscurity and soar to new heights. These companies, spanning the energy, technology and precious metals sectors, are not merely sleeping giants but strategic players with untapped potential. Read…
QuantumScape (NYSE:QS) has been teasing investors with the promise of solid-state batteries for years. The San Jose company said it was close to production last year. Then CEO Jagdeep Singh said improvements would be needed first. Besides the fact that money now costs money, there’s the fact that the promise market is getting crowded. Korea claims it has a better…
2024 promises to be a lucrative year in the stock market for many reasons. First of all, the Federal Reserve is on track to begin easing off in its efforts to cool an overheated economy. Interest rates are set to decrease with multiple projected cuts on the horizon. Beyond that though, the world continues to evolve at a rapid pace with…
In an era where digital fortification reigns supreme, three cybersecurity giants stand tall, reshaping the landscape of online protection. Read the article to learn about the trio’s financial prowess, innovative strides, and market dominance. These industry titans reveal their fiscal resilience and strategic maneuvers in adapting to an edgy digital threat landscape. Their strategies breed resilience and valuation growth as…
Certain smart money stocks catch the discerning eye of big players in investing, drawing in substantial investments. Delving into the strategies and growth patterns of three companies reveals intriguing insights into why these companies have piqued the interest of notable investors. Each company’s strengths and forward-looking strategies offer a glimpse into its potential for long-term growth and market dominance. Understanding…
Savvy investors are starting to look for some of the best stocks for slowing inflation. The latest reports show that inflation slowed dramatically in October. The Federal Reserve is likely done raising interest rates. It’s an excellent sign for the economy overall. It also means that investors should expect rate cuts in perhaps as early as this year propelling the…
The fields of gene editing and gene therapy have been growing since the first draft of the human genome map was finished in 2003. In 2022, gaps in that map were completed. But even before then, the roadmap gave researchers the opportunity to develop gene therapies to correct genetic abnormalities. Gene editing, which seeks to directly alter a patient’s genome itself,…
The stock market is recovering with solid earnings reports and the decision of the Fed to maintain the interest rate at the same level. While it will have a short-term positive impact on the market, investors who are looking to buy and hold for the long term need to look beyond the current ups and downs. Amid this development, it…
It’s the dream of every investor to uncover stocks with the potential to grow tenfold within a short span. While it may sound like a lofty goal, the article reveals that it’s not just a pipe dream. The article delves into the exciting journeys of three companies making waves in their respective industries. These are the stocks that can 10X…
The selloff in stocks continues. The downturn that began in August and accelerated in September is ongoing as we near the end of October. Since Aug. 1, the benchmark S&P 500 index has declined 7%. The drop in equities has largely been broad-based with few names or sectors spared. That said, there are a few stocks bucking the current downtrend and rising. A handful…